Intervention Effect of Probiotics in Gastric Cancer Patients with Complications of Coronary Heart Disease and Heart Failure

Table 2

Comparison of the gastrointestinal mucosal barrier between the two groups ().

Group		ET (EU/mL)	D-lactate (μg/mL)	PCT (μg/L)
Group B(n = 84)	Before treatment	0.25 ± 0.04	6.42 ± 0.61	0.96 ± 0.13
	4 weeks after treatment	0.10 ± 0.01	3.99 ± 0.32	0.41 ± 0.10
Group A(n = 84)	Before treatment	0.26 ± 0.05	6.43 ± 0.62	0.98 ± 0.15
	4 weeks after treatment	0.19 ± 0.03	4.51 ± 0.46	0.81 ± 0.13

Vs. group A, ; vs. before treatment, ^∗P < 0.05.